Trending Topics
Introduction
Brian Krob is a partner in Nixon Peabody's Corporate practice group. He represents corporate acquirers as well as private equity firms in their acquisitions and dispositions.
My focus
M&A and Corporate Transactions
I represent public and private companies in strategic corporate transactions, including acquisitions, dispositions, joint ventures, and investments. I work with clients across industries, with a particular focus in the technology, healthcare, and consumer verticals.
Private Equity
For my entire career, I have represented private equity funds in the acquisition and disposition of their portfolio companies. While the company is being held by the private equity fund, I work with management to resolve their day-to-day legal issues as they arise, with an ultimate view to preparing the company for disposition by the fund.
Looking ahead
Complexity in transactions will continue to rise. Almost all transactions now have international elements to them, whether representing an entity with foreign operations, a U.S. business seeking to make an acquisition abroad or a foreign investor seeking to deploy capital in the U.S. All of this is in a rising tide of uncertainty. Excellent counsel can provide practical legal strategies for managing these complexities.
Insights
- Moderator, Virtual Private Equity Panel, BDO USA LLP, Webinar, July 29, 2020
Admitted to practice
Illinois
Education
University of Illinois College of Law, J.D., magna cum laude, Order of the Coif
Associate Editor, University of Illinois Law Review
University of Kansas, B.A., with honors
Recognition
Brian has been recommended in The Legal 500 United States 2022 editorial for Next Generation Partners, M&A/Corporate and commercial—M&A: Middle-market (sub-$500m). He has also been recognized in previous years.
In the News
- Law360
Don't Miss It: Simpson, Latham guide week's hot deals
Boston Corporate partner David Martland and Chicago Corporate partner Brian Krob are mentioned in this roundup of notable deals for advising Merck in its acquisition of Intermolecular.May 10, 2019 - Law360
Appraisal Rights Waivers after Halpin V. Riverstone
Chicago Madison M&A and Corporate Transactions partner Brian Krob and Chicago Madison M&A and Corporate Transactions associate Kim Rovtar coauthored this article discussing Halpin v. Riverstone National, Inc.—a case questioning the effectiveness of waive appraisal rights.April 16, 2015 - <em>Law360</em>
Law360 Features Brian Krob in Dealmakers Q&A Series
Brian Krob is a corporate transactional attorney at Ungaretti & Harris LLP. In his 17 years of practice, he has been involved in virtually every type of transaction — from mergers and acquisitions to secured lending, securities offerings and private equity — and in a variety of industries, including health care, consumer products, food and beverage, and medical devices.Aug 13, 2014As a participant in Law360's Q&A series with dealmaking movers and shakers, Brian Krob shared his perspective on five questions.
Professionals in the Practice Area
View AllLori B. Green
Partner
Co-Leader, M&A and Corporate Transactions Team
Co-Leader, Cannabis Practice- Rochester
- Office:585.263.1236Mobile:585.281.3076
- lgreen@nixonpeabody.com
-
Todd Tidgewell
Partner / Leader, Corporate Practice Group- Albany
- Office:518.427.2705
- ttidgewell@nixonpeabody.com
-
Christopher P. Keefe
Partner
Chair, Business & Finance Department- Boston
- Office:617.345.1350
- ckeefe@nixonpeabody.com
-
